Impaired Na+-dependent glutamate uptake in platelets during depolarization of their plasma membrane

Neurochemistry International

Volumn 56, Issue 5, 2010, Pages 711-719

  Kasatkina, Ludmila ^a   Borisova, Tatiana ^a  

^a PALLADIN INSTITUTE OF BIOCHEMISTRY   (Ukraine)

Author keywords

Depolarization of the plasma membrane; Glutamate; Na+ dependent transporters; Rabbit blood platelets; Rat brain nerve terminals

Indexed keywords

ACRIDINE ORANGE; ADENOSINE DIPHOSPHATE; ALDOSTERONE; CARBON 14; FLUORESCENT DYE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; POTASSIUM CHLORIDE; RHODAMINE 6G; SODIUM ION; THROMBIN; THROMBOCYTE ACTIVATING FACTOR;

ACIDIFICATION; ACUTE KIDNEY FAILURE; ADRENAL CORTEX INSUFFICIENCY; AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CENTRAL NERVOUS SYSTEM; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; HEMOLYSIS; HEMOSTASIS; HOMEOSTASIS; HYPERKALEMIA; INJURY; LEUKOCYTOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SECRETORY GRANULE; STROKE; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ANIMALS; BLOOD PLATELETS; CELL MEMBRANE; CYTOPLASMIC GRANULES; FLOW CYTOMETRY; GLUTAMIC ACID; HYDROGEN-ION CONCENTRATION; HYPERKALEMIA; MALE; MEMBRANE POTENTIALS; MICROSCOPY, CONFOCAL; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; SODIUM; SYNAPTOSOMES;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 77949568888     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.02.008     Document Type: Article

References (51)

1. Ahnadi C.E., Sabrinah Chapman E., Lépine M., Okrongly D., Pujol-Moix N., Hernández A., Boughrassa F., Grant A.M. Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology system, fluorescence flow cytometry, and electron microscopy. Thromb. Haemost. 2003, 90:940-948.
2. Aiuchi T., Daimatsu T., Nakaya K., Nakamura Y. Fluorescence changes of rhodamine 6G associated with changes in membrane potential in synaptosomes. Biochim. Biophys. Acta 1982, 685:289-296.
3. 2+ influx into platelets by platelet-activating factor and other aggregation inducers. Eur. J. Biochem. 1991, 198:267-273.
4. + antiport in the development of hypertension and insulin resistance. J. Am. Soc. Nephrol. 1992, 3:1049-1063.
5. Begni B., Tremolizzo L., D'Orlando C., Bono M.S., Garofolo R., Longoni M., Ferrarese C. Substrate-induced modulation of glutamate uptake in human platelets. Br. J. Pharmacol. 2005, 145:792-799.
6. Berk M., Plein H., Belsham B. The specificity of platelet glutamate receptor supersensitivity in psychotic disorders. Life Sci. 2000, 66:2427-2432.
7. + indicator sodium-binding benzofuran isophthalate. J. Biol. Chem. 1990, 265:19543-19550.
8. 2+ influx pathway. J. Biol. Chem. 1991, 266:13153-13160.
9. Borisova T., Kasatkina L. Glutamate transporters of blood platelets as potential peripheral markers to analyze changes of glutamate transport activity in brain under altered gravity conditions. J. Grav. Physiol. 2007, 14:81-82.
10. Bos I.W., Hoogland G., Meine Jansen C.F., Willigen G., Spierenburg H.A., van den Berg L.H., de Graan P.N. Increased glutamine synthetase but normal EAAT2 expression in platelets of ALS patients. Neurochem. Int. 2006, 48:306-311.
11. Cotman C.W. Isolation of synaptosomal and synaptic plasma membrane fractions. Methods Enzymol. 1974, 31:445-452.
12. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
13. Ferrarese C., Begni B., Canevari C., Zoia C., Piolti R., Frigo M., Appollonio I., Frattola L. Glutamate uptake is decreased in platelets from Alzheimer's disease patients. Ann. Neurol. 2000, 47:641-643.
14. Ferrarese C., Sala G., Riva R., Begni B., Zoia C., Tremolizzo L., Galimberti G., Millul A., Bastone A., Mennini T., Balzarini C., Frattola L., Beghi E. Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology 2001, 56:270-272.
15. Ferrarese C., Tremolizzo L., Rigoldi M., Sala G., Begni B., Brighina L., Ricci G., Albizzati M.G., Piolti R., Crosti F., Dalprà L., Frattola L. Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease. Neurol. Sci. 2001, 22:65-66.
16. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J. Neurochem. 1984, 42:1-11.
17. Franconi F., Miceli M., Alberti L., Seghieri G., De Montis M.G., Tagliamonte A. Further insights into the anti-aggregating activity of NMDA in human platelets. Br. J. Pharmacol. 1998, 124(1):35-40.
18. Franconi F., Miceli M., De Montis M.G., Lupis Crisafi E., Bennardini F., Tagliamonte A. NMDA receptors play an anti-aggregating role in human platelets. Thromb. Haemost. 1996, 76(1):84-87.
19. Gottlieb M., Wang Y., Teichberg V.I. Blood-mediated scavenging of cerebrospinal fluid glutamate. J. Neurochem. 2003, 87:119-126.
20. Greenberg-Sepersky S.M., Simons E.R. Cation gradient dependence of the steps in thrombin stimulation of human platelets. J. Biol. Chem. 1984, 259:1502-1508.
21. + pump and a Donnan potential. J. Biol. Chem. 1983, 258:7876-7882.
22. Hallam T.J., Rink T.J. Responses to adenosine diphosphate in human platelets loaded with the fluorescent calcium indicator quin2. J. Physiol. 1985, 368:131-146.
23. Headley P.M., Grillner S. Excitatory amino acids and synaptic transmission: the evidence for a physiological function. Trends Pharmacol. Sci. 1990, 11:205-211.
24. Hoogland G., Bos I.W., Kupper F., van Willigen G., Spierenburg H.A., van Nieuwenhuizen O., de Graan P.N. Thrombin-stimulated glutamate uptake in human platelets is predominantly mediated by the glial glutamate transporter EAAT2. Neurochem. Int. 2005, 47:499-506.
25. Howard M.R., Ashwell S., Bond L.R., Holbrook I. Artefactual serum hyperkalaemia and hypercalcaemia in essential thrombocythaemia. J. Clin. Pathol. 2000, 53:105-109.
26. Krisanova N.V., Ttiksh I.O., Borisova T.A. Synaptopathy under conditions of altered gravity: changes in synaptic vesicle fusion and glutamate release. Neurochem. Int. 2009, 55:724-731.
27. Kruth H.S., Vaughan M. Quantification of low density lipoprotein binding and cholesterol accumulation by single human fibroblasts using fluorescence microscopy. J. Lipid Res. 1980, 21:123-130.
28. Kuo J.S., Chen S.F., Huang H.J., Yang C.S., Tsai P.J., Hsueh C.M. The involvement of glutamate in recall of the conditioned NK cell response. J. Neuroimmunol. 2001, 118:245-255.
29. Larson E., Howlett B., Jagendorf A. Artificial reductant enhancement of the Lowry method for protein determination. Anal. Biochem. 1986, 155:243-248.
30. MacIntyre D.E., Rink T.J. The role of platelet membrane potential in the initiation of platelet aggregation. Thromb. Haemost. 1982, 47:22-26.
31. Mahaut-Smith M.P., Rink T.J., Collins S.C., Sage S.O. Voltage-gated potassium channels and the control of membrane potential in human platelets. J. Physiol. 1990, 428:723-735.
32. Mahaut-Smith M.P., Sage S.O., Rink T.J. Receptor-activated single channels in intact human platelets. J. Biol. Chem. 1990, 265:10479-10483.
33. Mangano R., Schwarcz R. The human platelets as a model for the glutamatergic neuron: platelet uptake of l-glutamate. J. Neurochem. 1981, 36:1067-1076.
34. Maruyama Y. A patch-clamp study of mammalian platelets and their voltage-gated potassium current. J. Physiol. 1987, 391:467-485.
35. 3H]-glutamate uptake into platelets from patients with bipolar I disorder. Psychiatry Res. 2006, 141:343-347.
36. +-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J. Biol. Chem. 1999, 274:31891-31895.
37. Pipili E. Platelet membrane potential: simultaneous measurement of diSC3(5) fluorescence and optical density. Thromb. Haemost. 1985, 54:645-649.
38. Popov E.G., Gabbazov Z.A., Gavrilov I.Yu., Pozin E.Ya., Mejlumian A.G. Accumulation and release of acridine derivatives by intact platelets. Thomb. Res. 1987, 47:639-645.
39. Rainesalo S., Keränen T., Peltola J., Saransaari P. Glutamate uptake in blood platelets from epileptic patients. Neurochem. Int. 2003, 43:389-392.
40. Rosskopf D. Sodium-hydrogen exchange and platelet function. J. Thromb. Thrombolysis 1999, 8:15-24.
41. Sage S.O., Rink T.J. The kinetics of changes in intracellular calcium concentration in fura-2-loaded human platelets. J. Biol. Chem. 1987, 262:16364-16369.
42. + exchanger for the generation of procoagulant activity by porcine blood platelets. Platelets 2001, 12:436-442.
43. Sevastos N., Theodossiades G., Savvas S.P., Tsilidis K., Efstathiou S., Archimandritis A.J. Pseudohyperkalemia in patients with increased cellular components of blood. Am. J. Med. Sci. 2006, 331:17-21.
44. Sharp C.D., Hines I., Houghton J., Warren A., Jackson T.H., Jawahar A., Nanda A., Elrod J.W., Long A., Chi A., Minagar A., Alexander J.S. Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:2592-2598.
45. Tremolizzo L., DiFrancesco J.C., Rodriguez-Menendez V., Sirtori E., Longoni M., Cassetti A., Bossi M., El Mestikawy S., Cavaletti G., Ferrarese C. Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation. Neurosci. Lett. 2006, 404:262-265.
46. 2+ and protein kinase C in the serotonin (5-HT) transport in human platelets. Cell Calcium 2002, 31(5):235-244.
47. Wang Y., Gottlieb M., Teichberg V.I. An evaluation of erythrocytes as plasma glutamate scavengers for enhanced brain-to-blood glutamate efflux. Neurochem. Res. 2004, 29:755-760.
48. Weir E.K., Hong Z., Varghese A. The serotonin transporter: a vehicle to elucidate pulmonary hypertension?. Circ. Res. 2004, 94:1152-1154.
49. Wencel-Drake J.D., Feinberg H. ADP induced depolarization of human platelet membrane potential. Thromb. Haemost. 1985, 53:75-79.
50. Zoccarato F., Cavallini L., Alexandre A. The pH-sensitive dye acridine orange as a tool to monitor exocytosis/endocytosis in synaptosomes. J. Neurochem. 1999, 72:625-633.
51. Zoia C., Cogliati T., Tagliabue E., Cavaletti G., Sala G., Galimberti G., Rivolta I., Rossi V., Frattola L., Ferrarese C. Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease. Neurobiol. Aging 2004, 25:149-157.